Trailing-twelve-month (TTM) revenue is $945.29 Million with a year-over-year growth of +14.42%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $238,774,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $238,248,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $232,782,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $235,488,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $945,292,000 |
Current P/S: $2,621,102,451 market capitalization ÷ $945,292,000 TTM revenue = 2.77x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:35:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $235.49M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:37:45.113Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Insurance Revenue | $15M | $14M | $15M | $16M | $17M | $18M |
$945.29M
$945.29 Million
+14.42%
vs. $826.16M a year ago (TTM)
+14.08%
5 Year compound annual growth rate
1 Year
+14.42%
3 Year
+18.03%
5 Year
+14.08%
10 Year
+9.15%
15 Year
+7.29%
20 Year
+5.81%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $867.43M | +$81.44M | +10.36% |
| 2024 | $785.99M | +$123.64M | +18.67% |
| 2023 | $662.35M | +$125.35M | +23.34% |
| 2022 | $537.00M | +$42.25M | +8.54% |
| 2021 | $494.75M | +$3.49M | +0.71% |
| 2020 |
TTM Growth
+14.42%
3-Year CAGR
+18.03%
5-Year CAGR
+14.08%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $491.26M |
| ($16.14M) |
| (3.18%) |
| 2019 | $507.40M | +$42.60M | +9.17% |
| 2018 | $464.80M | +$39.67M | +9.33% |
| 2017 | $425.13M | +$25.93M | +6.49% |
| 2016 | $399.20M | +$14.30M | +3.71% |
